These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Erratum: Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum]. Cancer Manag Res; 2018; 10():613. PubMed ID: 29630065 [TBL] [Abstract][Full Text] [Related]
5. Erratum: Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]. Ther Clin Risk Manag; 2014; 10():913. PubMed ID: 25412931 [TBL] [Abstract][Full Text] [Related]
6. Erratum: Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives [Corrigendum]. J Blood Med; 2016; 7():233. PubMed ID: 27799836 [TBL] [Abstract][Full Text] [Related]
7. Erratum: Burden of uterine fibroids in Italy: epidemiology, treatment outcomes, and consumption of health care resources in more than 5,000 women [Corrigendum]. Clinicoecon Outcomes Res; 2017; 9():653. PubMed ID: 29081668 [TBL] [Abstract][Full Text] [Related]
8. Erratum: Burden of comorbidities among Japanese patients with atrial fibrillation: a case study of dyspepsia [Corrigendum]. Clin Exp Gastroenterol; 2013; 6():193. PubMed ID: 24098088 [TBL] [Abstract][Full Text] [Related]
9. Erratum: Long-term safety profile of tolvaptan in autosomal dominant polycystic kidney disease patients: TEMPO Extension Japan Trial [Corrigendum]. Drug Healthc Patient Saf; 2018; 10():67-68. PubMed ID: 30038524 [TBL] [Abstract][Full Text] [Related]
10. Corrigendum. Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254 [TBL] [Abstract][Full Text] [Related]